# CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)

URL: https://app.greenveil.ai/ingredients/ingredient_unii_hht01_znk31
Categories: pharma
Identifier: drug bank:DB05384

> CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED). Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 19 mg Compiled from 3 published data sources.

## Safety assessment

- Chemical concern: not yet assessed
- Is it a concern? We haven't assessed a concern score for this ingredient yet.
- Rationale: Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 19 mg

## Regulatory status

- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 19 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: GEL; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.45 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 50 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 600 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 64 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 8 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 180 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 214 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 81 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: 0.3 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 11 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 11 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SUSPENSION/ DROPS; Potency: 0.4 %w/v
- US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: GEL; Maximum daily exposure: 19 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 200 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as polymer.

## Data sources

- FDA Inactive Ingredient Database (updated 2026-01-09): https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-database-download
- FDA GSRS UNII (updated 2026-02-26): https://precision.fda.gov/uniisearch/
- openFDA Substance (updated 2026-05-24): https://api.fda.gov/other/substance.json?search=unii:HHT01ZNK31

_Assessed by Greenveil._